Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Scotiabank Analyst Reiterates Sector Perform Rating on FrancoNevada with Adjusted Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_Investment (2)
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Scotiabank analyst Tanya Jakusconek has reiterated a Sector Perform rating on Franco-Nevada (NYSE:FNV) on March 7, 2024, while adjusting the price target from $141 to $139. This update aligns with Jakusconek’s assessment of the company’s potential within its industry.

Franco-Nevada Corporation (FNV) Stock Price Surges by 3.48% on March 7, 2024

On March 7, 2024, Franco-Nevada Corporation (FNV) experienced a significant increase in its stock price, with shares rising by $3.81 since the previous market close. This represents a 3.48% increase in value, as the stock opened at $111.02, $1.51 higher than its previous closing price.

Franco-Nevada Corporation (FNV) Sees Significant Declines in Financial Performance on March 7, 2024

On March 7, 2024, Franco-Nevada Corporation (FNV) saw concerning trends in its financial performance. According to data from CNN Money, the company reported total revenue of $1.22 billion for the past year, marking a 7.48% decrease compared to the previous year. The total revenue for the fourth quarter was $303.50 million, remaining flat compared to the previous quarter.

The net income for FNV was reported at -$466.40 million for the past year, a significant 166.57% decrease compared to the previous year. The net income for the fourth quarter was even more concerning at -$982.50 million, marking a staggering 661.11% decrease compared to the previous quarter.

Earnings per share (EPS) for FNV also showed a downward trend, with an EPS of -$2.43 for the past year, reflecting a 166.54% decrease compared to the previous year. The EPS for the fourth quarter was reported at -$5.11, indicating a substantial 660.89% decrease compared to the previous quarter.

These financial metrics paint a grim picture of FNV’s performance on March 7, 2024. The company experienced declines in total revenue, net income, and earnings per share, indicating potential challenges and struggles in its operations. Investors and analysts may view these results as a cause for concern and may closely monitor FNV’s future financial reports to assess the company’s ability to reverse these negative trends and improve its financial performance.

Tags: FNV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Belden Introduces BEETLE Single Pair Ethernet Lite Managed Switch

Biotechnology Stock Market Today (1)

Positive Results of Phase 1 Trial of ALGAPV527 for Solid Tumors Expressing 5T4 Antigen

Financial Moves of First Watch Restaurant Group Incs Chief Brand Officer

Recommended

Amgen Stock

Amgen’s Market Paradox: Strong Fundamentals Clash With Stock Performance

4 months ago
Adobe Stock

Adobe Shares Plunge to New Depths Amid Institutional Sell-Off

3 months ago
Omv Stock

OMV Shares Stabilize as Romanian Power Plant Resumes Operations

2 months ago
MKL stock news

Lynch Asset Management Inc. Decreases Stake in The Cigna Group, Analysts Offer Mixed Ratings and Price Targets

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

SuRo Capital Sharpens Focus on AI Infrastructure Investments

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Trending

Tilray Stock
Analysis

Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins

by Jackson Burston
February 8, 2026
0

Tilray Brands, Inc. continues to build on its strong January performance with two significant strategic developments. The...

Ammo Stock

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

February 8, 2026
Berry Petroleum Stock

California Resources Navigates Post-Merger Integration and Regulatory Landscape

February 8, 2026
KemPharm Stock

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

February 8, 2026
Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins
  • Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test
  • California Resources Navigates Post-Merger Integration and Regulatory Landscape

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com